FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
-- FoundationOne CDx is the First Next Generation Sequencing Test for All Solid Tumors to Complete the FDA/CMS Parallel Review Process and...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
-- Final NCD Significantly Expands Patient Access Beyond the Preliminary NCD -- Foundation Medicine, Inc. (NASDAQ:FMI) today announced...
-- Chugai to Commercialize Foundation Medicine’s Suite of Comprehensive Genomic Profiling (CGP) Services in Japan, Expanding Patient Access...
Foundation Medicine, Inc. (NASDAQ:FMI) and Guardant Health, Inc. announced an agreement to settle false advertising challenges that the...
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that members of the company's management team will present at Cowen & Company’s...
As filed with the Securities and Exchange Commission on March 7, 2018 Registration No. 333-  ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.